NEUARTIGES PROTEIN

European patent · EP2238159 · In force

Register entry

Publication number
EP2238159
Application number
EP08866070
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 25, 2008
Published
Oct 13, 2010
Granted
Jul 17, 2013
Protection ends at the latest
Dec 24, 2028
Next annual fee due
Dec 31, 2026
IPC classes
C07K 14/47 (2006.01)
Priority
US 9216 P 27.12.2007
PCT application
PCT/IL2008/001674 25.12.2008
PCT publication
WO2009/083968 09.07.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 24, 2026

    Change

    Published in Swissreg on 24.01.2026

  2. Apr 9, 2025

    Agent removed

    Representative
    Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano (removed)

    Published in Swissreg on 09.04.2025

  3. Apr 9, 2025

    Agent entered

    Representative
    PRAXI Intellectual Property SA, Via San Gottardo 15, 6900 Lugano

    Published in Swissreg on 09.04.2025

  4. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  5. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  6. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  7. Oct 9, 2013

    Agent entered

    Representative
    Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano

    Published in Swissreg on 09.10.2013

  8. Jul 17, 2013

    Granted

    Published in Swissreg on 17.07.2013

Parties

Holder

Two To Biotech Ltd.

9/7 Rosenblat street Ramot Gimmel, 97460 Jerusalem, IL

Agent

Praxi Intellectual Property SA

PRAXI Intellectual Property SA

Via San Gottardo 15, 6900 Lugano

Inventor

SANDLER, Tamar

97460 Jerusalem, IL

DEVARY, Orly

97460 Jerusalem, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.